HB 1610: establishing the manufacturer pharmaceutical drug take-back program

HB 1610: establishing the manufacturer pharmaceutical drug take-back program
  • Requires the Department of Health and Human Services to operate a pharmaceutical drug take-back program to be funded by drug manufacturers
  • Prime sponsor: Rep. Tom Loughman
  • Position: Support

Click here to read the billhttp://gencourt.state.nh.us/bill_status/billText.aspx?sy=2020&id=1234&tx...

Bill Status
  • Committee
  • Public Hearing
  • Executive Session
  • Full Body Vote
  • Committee
  • Public Hearing
  • Executive Session
  • Full Body Vote